Suchergebnisse - "Vermeire, S"

PubPharm (33)

1

Review article : pharmacological aspects of anti-TNF biosimilars in inflammatory bowel diseases

enthalten in: Alimentary pharmacology & therapeutics | 2015

von Papamichael, K. | Van Stappen, T. | Jairath, V. | +8

2

Clinical and scientific aspects related to biosimilars in inflammatory bowel diseases (IBD) : position document of the Belgian IBD Research & Development Group (BIRD)

enthalten in: Acta gastro-enterologica Belgica | 2015

von Vermeire, S. | Louis, E. | Dewit, O. | +9

3

Prior response to infliximab and early serum drug concentrations predict effects of adalimumab in ulcerative colitis

enthalten in: Alimentary pharmacology & therapeutics | 2014

von Baert, F. | Vande Casteele, N. | Tops, S. | +6

4

Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients

enthalten in: Journal of Crohn's & colitis | 2013

von Baert, F. | Glorieus, E. | Reenaers, C. | +57

5

Letter : detection of infliximab levels and anti-infliximab antibodies--comparison of three different assays; authors' reply

enthalten in: Alimentary pharmacology & therapeutics | 2013

von Buurman, D. | Vande Casteele, N. | Sturkenboom, M. | +6

CommentOn: Aliment Pharmacol Ther. 2012 Oct;36(8):765-71. - PMID 22928581

6

Safety and cost of infliximab for the treatment of Belgian pediatric patients with Crohn's disease

enthalten in: Acta gastro-enterologica Belgica | 2012

von De Greef, E. | Hoffman, I. | D'Haens, G. | +20

7

Ustekinumab induction and maintenance therapy in refractory Crohn's disease

enthalten in: The New England journal of medicine | 2012

von Sandborn, W. | Gasink, C. | Gao, L. | +115

CommentIn: Nat Rev Gastroenterol Hepatol. 2012 Dec;9(12):690. - PMID 23147667

8

Detection of infliximab levels and anti-infliximab antibodies : a comparison of three different assays

enthalten in: Alimentary pharmacology & therapeutics | 2012

von Vande Casteele, N. | Buurman, D. | Sturkenboom, M. | +6

CommentIn: Aliment Pharmacol Ther. 2013 Jan;37(1):153-4. - PMID 23205472

9

Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis

enthalten in: Journal of Crohn's & colitis | 2012

von De Vos, M. | Dewit, O. | D'Haens, G. | +37

10

Early serial trough and antidrug antibody level measurements predict clinical outcome of infliximab and adalimumab treatment

enthalten in: Gut | 2012

von Vande Casteele, N. | Ballet, V. | Van Assche, G. | +3

CommentOn: Gut. 2011 Jan;60(1):41-8. - PMID 20519742